← Research LibraryThe BriefFY2025 10-K · headline figures audited against SEC data
Revenue decreased 18.3% to $3.47B, while Net income decreased 756.4% to ($2.24B).
The read at a glance✓ Audited against SEC data
- Scale — FY2025 revenue $3.47BWatch
- Profitability — Net income ($2.24B)Watch
- Cash generation — Free cash flow N/ANote
- Accounting — Formula distress score · manipulation and earnings-quality screens not computedWatch
- Insiders — 3 buys; 2 sells in 365 daysOK
- Capital — dividends paid were $291.3M; share repurchases were $0Note
Business
FMC CORP: We develop, market and sell all three major classes of crop protection chemicals (insecticides, herbicides and fungicides) as well as biologicals, crop nutrition, and seed treatment products, which we group as plant health.
Where the revenue comes from
Fiscal 2025, as FMC CORP reports it. History and quarterly detail are in the app.
- Insecticides$1.6B
- Herbicides$1.2B
- Fungicides$362.8M
- Plant Health$190.9M
- Other$94.1M
Leadership changes
From FMC CORP's own filings, the day they're filed.
- Ronaldo Pereira · President · departureeff. 2025-12-15
- Anthony DiSilvestro · Directors · departureeff. 2025-12-03
- Sara Velazquez Ponessa · President · appointmenteff. 2025-06-01
Latest filings
- 10-Q · Quarterly report2026-07-30
- 8-K · Company announcement2026-07-29
- 8-K · Company announcement2026-07-01
- 8-K · Company announcement2026-06-23
- 8-K · Company announcement2026-06-23
In the full recordFree for 14 days
- What changed🔒
- Insider signal🔒
- Growth quality🔒
- Margins & accounting🔒
- Capital allocation🔒
- Real risks🔒
- The long arc🔒
- Company history🔒
- The filings, readable — with what changed vs the prior year highlighted🔒
- Full financial statements, industry-aware, sources cited throughout🔒
- Forensic score history & components — the trend, not one year🔒
- Ownership: insider buys/sells, clusters, activist stakes🔒
- Ana — ask about FMC CORP, every answer cited to the official filings🔒
Every figure comes from the company's filings, and analysis whose figures don't match SEC data is rejected before publication.
14-day free trial, no credit card. For research purposes only; not investment advice.